UK's first mandatory healthcare-associated infection data
This article was originally published in Clinica
Executive Summary
Almost 45,000 cases of Clostridium difficile infection were recorded in England in 2004, under the first mandatory healthcare-associated infection (HAI) surveillance schemes. The data released today by the Department of Health and the Health Protection Agency (HPA) also covers bacteraemia rates associated with glycopeptide-resistant enterococci (GREs), of which 620 were recorded in the year ending September 2004.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.